Physician profile
Bradford L Currier
NPI 1841263381
$2,027,958.56
in general payments reported to CMS, 2019-2025
8 companies · $132K in 2025
The $132K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42K · 2020: $33K · 2021: $161K · 2022: $874K · 2023: $618K · 2024: $167K · 2025: $132K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $918K · Food and Beverage: $156 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $88.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $917,802.84 |
| Food and Beverage | $155.62 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $88.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $988,231.59 | 2022-2023 | |
| Depuy Synthes Products, INC. | $881,145.27 | 2019-2025 | Synapse, Mountaineer |
| Zimmer Biomet Holdings, INC. | $156,239.29 | 2019-2022 | |
| Medical Device Business Services, INC. | $2,047.50 | 2021 | |
| Medtronic, INC. | $155.62 | 2023 | Mazor X System |
| Spineology INC. | $88.20 | 2024 | Optimesh Expandable Interbody Fusion System |
| Depuy Synthes Sales INC. | $36.08 | 2019 | |
| Surgalign Spine Technologies, INC. | $15.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$110,838.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradford Currier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.